Virtual Investor is a leading platform providing investors with direct access to innovative companies, management teams and thought leaders.
Featured Event:
5 for ’25
Featured Companies
Covered Companies
Covered Companies
Series
What This Means
Featuring: Senti Bio
April 21, 2025
Moderated discussion with Stephen Strickland, MD, MSCI, internationally respected leukemia researcher, Director of Leukemia Research for Sarah Cannon Research Institute and Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio
What This Means
Featuring: Sonnet BioTherapeutics
April 16, 2025
Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010
What This Means
Featuring: Xenetic Biosciences
April 9, 2025
Dr. Reid Bissonnette, Executive Consultant for Translational Research and Development at Xenetic, discusses positive preclinical data recently presented at the Society for Immunotherapy of Cancer (SITC) Spring Scientific 2025 Cell Therapy Meeting.
What This Means
Featuring: Sonnet BioTherapeutics
March 26, 2025
Sonnet BioTherapeutics Successfully Completes First Safety Review of SON-1010 in Combination with Trabectedin in Certain Sarcomas
Past Events
New to Virtual Investor
Closing Bell
Live What This Means
Closing Bell Series
New to the Street
Live What This Means
Closing Bell Series
Closing Bell Series
Past Events
Join Us
Sign up for email alerts to stay up-to-date on the latest Virtual Investor events
By submitting this form, you are consenting to receive marketing emails from: Virtual Investor. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact